Elanco Animal Health (ELAN) Now Covered by William Blair

Share on StockTwits

Stock analysts at William Blair assumed coverage on shares of Elanco Animal Health (NASDAQ:ELAN) in a research report issued to clients and investors on Monday, The Fly reports. The brokerage set a “market perform” rating on the stock.

A number of other brokerages also recently weighed in on ELAN. UBS Group started coverage on shares of Elanco Animal Health in a research report on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 price objective for the company. Citigroup started coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They issued a “buy” rating and a $37.00 price objective for the company. Argus started coverage on shares of Elanco Animal Health in a research report on Tuesday, January 15th. They issued a “buy” rating and a $37.00 price objective for the company. Credit Suisse Group reiterated a “hold” rating and issued a $33.00 price objective on shares of Elanco Animal Health in a research report on Friday, January 4th. Finally, Zacks Investment Research upgraded shares of Elanco Animal Health from a “hold” rating to a “buy” rating and set a $36.00 price objective for the company in a research report on Monday, December 17th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $31.10.

NASDAQ:ELAN traded up $0.02 during mid-day trading on Monday, hitting $29.71. The company’s stock had a trading volume of 9,173,400 shares, compared to its average volume of 2,629,161. Elanco Animal Health has a 1 year low of $28.00 and a 1 year high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings results on Wednesday, February 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. The business had revenue of $799.30 million during the quarter, compared to analysts’ expectations of $804.07 million. Elanco Animal Health’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.12 earnings per share.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. First Manhattan Co. bought a new position in shares of Elanco Animal Health in the 3rd quarter worth approximately $348,000. Massachusetts Financial Services Co. MA bought a new position in shares of Elanco Animal Health in the 3rd quarter worth approximately $48,580,000. FNY Investment Advisers LLC purchased a new stake in shares of Elanco Animal Health in the 3rd quarter worth approximately $456,000. Daiwa Securities Group Inc. purchased a new stake in shares of Elanco Animal Health in the 3rd quarter worth approximately $425,000. Finally, Wells Fargo & Company MN purchased a new stake in shares of Elanco Animal Health in the 3rd quarter worth approximately $79,056,000.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Featured Story: Risk Tolerance

The Fly

Analyst Recommendations for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Gentex Co.  Position Lifted by Stevens Capital Management LP
Gentex Co. Position Lifted by Stevens Capital Management LP
A. O. Smith Corp  Shares Sold by Stevens Capital Management LP
A. O. Smith Corp Shares Sold by Stevens Capital Management LP
Stevens Capital Management LP Raises Holdings in Centene Corp
Stevens Capital Management LP Raises Holdings in Centene Corp
Unitil Co.  Holdings Boosted by Teachers Advisors LLC
Unitil Co. Holdings Boosted by Teachers Advisors LLC
Verition Fund Management LLC Purchases Shares of 35,453 PepsiCo, Inc.
Verition Fund Management LLC Purchases Shares of 35,453 PepsiCo, Inc.
Pfizer Inc.  Shares Bought by Twin Capital Management Inc.
Pfizer Inc. Shares Bought by Twin Capital Management Inc.


Leave a Reply

 
© 2006-2019 Zolmax.